IL94062A - History of Pyrimidine Process for their preparation and pharmaceutical preparations containing them - Google Patents

History of Pyrimidine Process for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL94062A
IL94062A IL9406290A IL9406290A IL94062A IL 94062 A IL94062 A IL 94062A IL 9406290 A IL9406290 A IL 9406290A IL 9406290 A IL9406290 A IL 9406290A IL 94062 A IL94062 A IL 94062A
Authority
IL
Israel
Prior art keywords
alkyl
methyl
phenyl
formula
ethyl
Prior art date
Application number
IL9406290A
Other languages
English (en)
Hebrew (he)
Other versions
IL94062A0 (en
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898909054A external-priority patent/GB8909054D0/en
Priority claimed from GB898910548A external-priority patent/GB8910548D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL94062A0 publication Critical patent/IL94062A0/xx
Publication of IL94062A publication Critical patent/IL94062A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9406290A 1989-04-21 1990-04-11 History of Pyrimidine Process for their preparation and pharmaceutical preparations containing them IL94062A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909054A GB8909054D0 (en) 1989-04-21 1989-04-21 Amino heterocycles
GB898910548A GB8910548D0 (en) 1989-05-08 1989-05-08 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
IL94062A0 IL94062A0 (en) 1991-01-31
IL94062A true IL94062A (en) 1995-11-27

Family

ID=26295250

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9406290A IL94062A (en) 1989-04-21 1990-04-11 History of Pyrimidine Process for their preparation and pharmaceutical preparations containing them

Country Status (29)

Country Link
US (1) US5223505A (fr)
EP (1) EP0422178B1 (fr)
JP (1) JP2528218B2 (fr)
KR (1) KR920700203A (fr)
CN (1) CN1024793C (fr)
AT (1) ATE112561T1 (fr)
AU (1) AU635260B2 (fr)
BG (1) BG93508A (fr)
CA (1) CA2014457C (fr)
DE (1) DE69013112T2 (fr)
DK (1) DK0422178T3 (fr)
ES (1) ES2064727T3 (fr)
FI (1) FI95377C (fr)
GB (1) GB2230527B (fr)
GR (1) GR1000371B (fr)
HR (1) HRP930793A2 (fr)
HU (1) HU209586B (fr)
IE (1) IE63502B1 (fr)
IL (1) IL94062A (fr)
MW (1) MW9090A1 (fr)
MY (1) MY105637A (fr)
NO (1) NO177054C (fr)
NZ (1) NZ233292A (fr)
PL (2) PL165917B1 (fr)
PT (1) PT93823B (fr)
RU (1) RU2108329C1 (fr)
SI (1) SI9010799A (fr)
WO (1) WO1990012790A1 (fr)
YU (1) YU79990A (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
BR9908004A (pt) 1998-02-17 2001-12-18 Tularik Inc Composto, composição e método para prevençãoou supressão de uma infecção viral
BRPI9909191B8 (pt) 1998-03-27 2021-07-06 Janssen Pharmaceutica Nv derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende
DE19851421A1 (de) * 1998-11-07 2000-05-11 Boehringer Ingelheim Pharma Neue Pyrimidine, deren Herstellung und Verwendung
JP4919566B2 (ja) 1999-09-24 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗ウイルス組成物
US6410726B1 (en) * 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
CZ20033053A3 (en) * 2001-05-14 2004-05-12 Bristol@Myersásquibbápharmaácompany Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
HRP20050089B1 (hr) 2002-07-29 2015-06-19 Rigel Pharmaceuticals Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
US20040242568A1 (en) 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
CN1984660B (zh) * 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
JP4886511B2 (ja) 2003-07-30 2012-02-29 ライジェル ファーマシューティカルズ， インコーポレイテッド ２，４−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法
EP1506967B1 (fr) 2003-08-13 2007-11-21 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidyl peptidase.
EP1699777B1 (fr) 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidylpeptidase
MXPA06010571A (es) 2004-03-15 2007-02-16 Takeda Pharmaceutical Inhibidores de dipeptidil peptidasa.
ATE540035T1 (de) 2004-11-24 2012-01-15 Rigel Pharmaceuticals Inc Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen
EP1828192B1 (fr) 2004-12-21 2014-12-03 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidyle peptidase
EP1833482A4 (fr) 2005-01-03 2011-02-16 Myriad Genetics Inc Composés bicycliques azotés et utilisation thérapeutique associée
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CN101115761B (zh) 2005-01-19 2012-07-18 里格尔药品股份有限公司 2,4-嘧啶二胺化合物的前药及其应用
JP2008540436A (ja) * 2005-05-03 2008-11-20 ライジェル ファーマシューティカルズ， インコーポレイテッド Ｊａｋキナーゼインヒビターおよびそれらの使用
CA2609716C (fr) 2005-05-26 2014-10-14 Tibotec Pharmaceuticals Ltd. Procede de preparation de 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
ME02005B (fr) 2005-09-14 2012-08-31 Takeda Pharmaceuticals Co Inhibiteurs de la dipeptidyl peptidase permettant de traiter le diabete
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
WO2007089774A2 (fr) * 2006-01-31 2007-08-09 Yale University Compositions et procédés de traitement de troubles cognitifs
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
TW200904437A (en) * 2007-02-14 2009-02-01 Janssen Pharmaceutica Nv 2-aminopyrimidine modulators of the histamine H4 receptor
US20080217501A1 (en) * 2007-02-14 2008-09-11 Chad Jensen Power a-frame
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
TWI468407B (zh) * 2008-02-06 2015-01-11 Du Pont 中離子農藥
WO2012135697A2 (fr) * 2011-03-30 2012-10-04 H. Lee Moffitt Cancer Center & Research Institute Inc. Nouveaux inhibiteurs de la rho-kinase et leurs procédés d'utilisation
WO2018187652A1 (fr) 2017-04-06 2018-10-11 Janssen Pharmaceutica Nv Dérivés de 2,4-diaminopyrimidine en tant que modulateurs de l'histamine h4
EP3697777A1 (fr) 2017-10-19 2020-08-26 eFFECTOR Therapeutics, Inc. Inhibiteurs de benzimidazole-indole de mnk1 et mnk2

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB815833A (en) * 1956-09-26 1959-07-01 Boots Pure Drug Co Ltd Phenanthridine compounds
BE492034A (fr) * 1948-11-05
US2784124A (en) * 1953-07-01 1957-03-05 Howard R Moore Method of coating ferrous metal surface and composition therefor
US2748124A (en) * 1954-05-06 1956-05-29 Searle & Co 1-(4-anilino-2-pyrimidino)-3-alkylureas
US2845425A (en) * 1956-10-04 1958-07-29 Lilly Co Eli Substituted aminopyrimidines
DE1241832B (de) * 1963-02-23 1967-06-08 Hoechst Ag Verfahren zur Herstellung von Pyrimidiniumverbindungen
DE1445740A1 (de) * 1963-09-04 1968-11-28 Bayer Ag Verfahren zur Herstellung von Bispyrimidinium-Verbindungen
GB1229413A (fr) * 1967-06-14 1971-04-21
IN142539B (fr) * 1974-05-10 1977-07-23 Ciba Geigy India Ltd
US4339453A (en) * 1979-07-23 1982-07-13 Merck & Co., Inc. Antimicrobial aminopyrimidinium salts
EP0139613A1 (fr) * 1983-08-29 1985-05-02 Ciba-Geigy Ag Dérivés de la N-(nitro-2 phényl) amino-4 pyrimidine, leur préparation et leur application
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
DE3717480A1 (de) * 1987-05-23 1988-12-01 Shell Agrar Gmbh & Co Kg Neue herbizid und mikrobizid wirksame 2,6-diaminopyrimidine
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
FI906307A0 (fi) 1990-12-20
HU903555D0 (en) 1991-05-28
CN1024793C (zh) 1994-06-01
JPH03505741A (ja) 1991-12-12
RU2108329C1 (ru) 1998-04-10
YU79990A (en) 1991-10-31
DE69013112T2 (de) 1995-01-26
GR1000371B (el) 1992-06-30
NO177054B (no) 1995-04-03
CA2014457C (fr) 1999-09-28
US5223505A (en) 1993-06-29
FI95377C (fi) 1996-01-25
BG93508A (bg) 1993-12-24
KR920700203A (ko) 1992-02-19
PL165917B1 (pl) 1995-03-31
EP0422178A1 (fr) 1991-04-17
NO905519D0 (no) 1990-12-20
MY105637A (en) 1994-11-30
WO1990012790A1 (fr) 1990-11-01
DK0422178T3 (da) 1994-12-19
FI95377B (fi) 1995-10-13
EP0422178B1 (fr) 1994-10-05
PT93823A (pt) 1990-11-20
NO177054C (no) 1995-07-12
NZ233292A (en) 1992-05-26
GB2230527A (en) 1990-10-24
IL94062A0 (en) 1991-01-31
ATE112561T1 (de) 1994-10-15
GB2230527B (en) 1993-05-05
NO905519L (no) 1991-02-20
PL165502B1 (pl) 1994-12-30
HRP930793A2 (en) 1996-08-31
GB9007964D0 (en) 1990-06-06
PT93823B (pt) 1996-09-30
CN1047080A (zh) 1990-11-21
ES2064727T3 (es) 1995-02-01
IE63502B1 (en) 1995-05-03
AU5435490A (en) 1990-11-16
HU209586B (en) 1994-08-29
IE901258L (en) 1990-10-21
JP2528218B2 (ja) 1996-08-28
CA2014457A1 (fr) 1990-10-21
SI9010799A (en) 1995-08-31
HUT56080A (en) 1991-07-29
MW9090A1 (en) 1991-11-13
GR900100304A (en) 1991-09-27
DE69013112D1 (de) 1994-11-10
AU635260B2 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
CA2014457C (fr) Derives de pyrimidine
FI92697C (fi) Menetelmä lääkeaineina käyttökelpoisten imidatso/4,5-b/kinolinyylioksialkaanihappoamidien valmistamiseksi
DE60110844T2 (de) Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
EP3812387A1 (fr) Inhibiteurs de protéine kinase hétérocycliques
US7312330B2 (en) Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
US20100197684A1 (en) Substituted heterocyclic compounds
SK90799A3 (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
AU2007254491A1 (en) Compositions and methods for FGF receptor kinases inhibitors
WO1993004047A1 (fr) Derives de quinazoline utilises comme inhibiteurs de transcriptase inverse d'hiv
JP2007517045A (ja) イオンチャネルリガンドとしてのビシクロヘテロアリールアミン化合物、およびこれらを使用する方法
IL191213A (en) Transformed derivatives in the cycles of pyrimidone
JPH06145170A (ja) ヘテロ環式化合物、その製法及びこれを含有する高血圧及びうつ血性心不全治療用医薬組成物
CA2040107A1 (fr) Derives d'amines
US5332737A (en) Amino-1,3,5-triazines and their anhydrobase derivatives as agents for cardiovascular system
AU641960B2 (en) Pyrimidine derivatives
DD297406A5 (de) Pyrimidinderivate
HK40041458A (en) Heterocyclic protein kinase inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees